Jane Blazeby

48.9k total citations · 14 hit papers
477 papers, 25.0k citations indexed

About

Jane Blazeby is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jane Blazeby has authored 477 papers receiving a total of 25.0k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Surgery, 116 papers in Oncology and 113 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jane Blazeby's work include Esophageal Cancer Research and Treatment (92 papers), Health Systems, Economic Evaluations, Quality of Life (82 papers) and Delphi Technique in Research (79 papers). Jane Blazeby is often cited by papers focused on Esophageal Cancer Research and Treatment (92 papers), Health Systems, Economic Evaluations, Quality of Life (82 papers) and Delphi Technique in Research (79 papers). Jane Blazeby collaborates with scholars based in United Kingdom, Netherlands and United States. Jane Blazeby's co-authors include Paula Williamson, Douglas G. Altman, Mike Clarke, Derek Alderson, Elizabeth Gargon, Jenny Donovan, Kerry Avery, Sara Brookes, Emma McIntosh and Neil Craig and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Jane Blazeby

456 papers receiving 24.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

2021 2.8k citations Kathryn Skivington, Lynsay Matthews et al. profile →
The COMET Handbook: version 1.0

2017 1.1k citations Paula Williamson, Jane Blazeby et al. Trials profile →
Developing core outcome sets for clinical trials: issues to consider

2012 1.1k citations Paula Williamson, Jane Blazeby et al. Trials profile →
Reporting of Patient-Reported Outcomes in Randomized Trials

2013 890 citations Jane Blazeby et al. profile →
Guidelines for the management of oesophageal and gastric cancer

2011 481 citations Jane Blazeby et al. profile →
Challenges in evaluating surgical innovation

2009 442 citations Jonathan Cook, Jane Blazeby et al. profile →
Core Outcome Set-STAndards for Development: The COS-STAD recommendations

2017 429 citations Jane Blazeby, Paula Williamson et al. profile →
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

2013 405 citations Jane Blazeby et al. profile →
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement

2016 391 citations Jane Blazeby, Paula Williamson et al. profile →
Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update

2021 266 citations Kathryn Skivington, Lynsay Matthews et al. Health Technology Assessment profile →
Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies

2017 247 citations Kerry Avery, Paula Williamson et al. BMJ Open profile →
No Surgical Innovation Without Evaluation

2018 230 citations Jane Blazeby, Marion Campbell et al. profile →
Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer

2022 88 citations Eric Lim, Tim Batchelor et al. profile →
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

2024 36 citations Kathryn Skivington, Lynsay Matthews et al. profile →

Peers

Countries citing papers authored by Jane Blazeby

Since Specialization

Citations

This map shows the geographic impact of Jane Blazeby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Blazeby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Blazeby more than expected).

Fields of papers citing papers by Jane Blazeby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Blazeby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Blazeby. The network helps show where Jane Blazeby may publish in the future.

Co-authorship network of co-authors of Jane Blazeby

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Blazeby. A scholar is included among the top collaborators of Jane Blazeby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Blazeby. Jane Blazeby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monitoring the safe delivery of new invasive interventional procedures and devices: an analysis of NHS organisation policies 2025 ·BMJ Open Quality ·(unknown), Sian Cousins, (unknown), Hollie Richards, Leila Rooshenas, Jane Blazeby	0
2	Examining the application of the IDEAL framework in the reporting and evaluation of innovative invasive procedures: secondary qualitative analysis of a systematic review 2024 ·BMJ Open ·Hollie Richards, Sian Cousins, (unknown), Daisy Elliott, Rhiannon Macefield, (unknown), (unknown), Max Shah, (unknown), Natalie Blencowe, Jane Blazeby	0
3	Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review 2023 ·Journal of Clinical Epidemiology ·Anthony Muchai Manyara, Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Valerie Wells, Jane Blazeby, Nancy J. Butcher, Sylwia Bujkiewicz, An‐Wen Chan, Gary S. Collins, Dalia Dawoud, Martin Offringa, Mario Ouwens, Joseph S. Ross, Rod S Taylor, Oriana Ciani	12
4	How do pilot and feasibility studies inform randomised placebo-controlled trials in surgery? A systematic review 2023 ·BMJ Open ·Sian Cousins, (unknown), Katy Chalmers, Marion Campbell, David Beard, Natalie Blencowe, Jane Blazeby	2
5	Identification of outcomes to inform the development of a core outcome set for surgical innovation: a targeted review of case studies of novel surgical devices 2022 ·BMJ Open ·Nicholas Wilson, Rhiannon Macefield, (unknown), (unknown), (unknown), Emily Kirkham, Natalie Blencowe, Angus McNair, Barry Main, Jane Blazeby, Kerry Avery, Shelley Potter	1
6	Managing clustering effects and learning effects in the design and analysis of randomised surgical trials: a review of existing guidance 2022 ·Trials ·Elizabeth J. Conroy, Jane Blazeby, Girvan Burnside, Jonathan Cook, Carrol Gamble	1
7	Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT 2022 ·Health Technology Assessment ·Eric Lim, Rosie A Harris, Holly E. McKeon, Tim Batchelor, Joel Dunning, Michael Shackcloth, Vladimir Anikin, Babu Naidu, Elizabeth Belcher, Mahmoud Loubani, Vipin Zamvar, Lucy Dabner, (unknown), Elizabeth A Stokes, Sarah Wordsworth, Sangeetha Paramasivan, Alba Realpe, Daisy Elliott, Jane Blazeby, Chris Rogers	45
8	Qualitative documentary analysis of guidance on information provision and consent for the introduction of innovative invasive procedures including surgeries within NHS organisations’ policies in England and Wales 2022 ·BMJ Open ·(unknown), Hollie Richards, Jesmond Zahra, Sian Cousins, Daisy Elliott, Nicholas Wilson, Sangeetha Paramasivan, Kerry Avery, John Mathews, Barry Main, Robert J. Hinchliffe, Natalie Blencowe, Jane Blazeby	2
9	Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update breakdown → 2021 ·Health Technology Assessment ·Kathryn Skivington, Lynsay Matthews, Sharon Simpson, Peter Craig, Janis Baird, Jane Blazeby, Kathleen Boyd, Neil Craig, David French, Emma McIntosh, Mark Petticrew, Jo Rycroft‐Malone, Martin White, Laurence Moore	266
10	Using qualitative research methods to understand how surgical procedures and devices are introduced into NHS hospitals: the Lotus study protocol 2021 ·BMJ Open ·Daisy Elliott, Natalie Blencowe, Sian Cousins, Jesmond Zahra, (unknown), John Mathews, Sangeetha Paramasivan, (unknown), Angus McNair, (unknown), Hollie Richards, Sina Hossaini, (unknown), Barry Main, Shelley Potter, Kerry Avery, Jenny Donovan, Jane Blazeby	3
11	A systematic review and in‐depth analysis of outcome reporting in early phase studies of colorectal cancer surgical innovation 2020 ·Colorectal Disease ·(unknown), Rhiannon Macefield, Nick Wilson, Jane Blazeby, Kerry Avery, Shelley Potter, Angus McNair	7
12	Systematic review of clinical outcome reporting in randomised controlled trials of burn care 2019 ·BMJ Open ·Amber Young, Anna Davies, (unknown), Sara Brookes, Jane Blazeby	23
13	Impact of question order on prioritisation of outcomes in the development of a core outcome set: a randomised controlled trial 2018 ·Trials ·(unknown), Sara Brookes, (unknown), Kerry Avery, Karen Coulman, Jane Blazeby	24
14	Protocol for the systematic review of the reporting of transoral robotic surgery 2018 ·BMJ Open ·Barry Main, Natalie Blencowe, (unknown), Sian Cousins, Kerry Avery, (unknown), Philip J. Radford, Daisy Elliott, Ben Byrne, Nicholas Wilson, Robert J. Hinchliffe, Jane Blazeby	5
15	Core information set for informed consent to surgery for oral or oropharyngeal cancer: A mixed‐methods study 2017 ·Clinical Otolaryngology ·Barry Main, Angus McNair, Simon Haworth, Leila Rooshenas, Ceri Hughes, Paul Tierney, Jenny Donovan, Steve Thomas, Jane Blazeby	9
16	Exploring methods the for selection and integration of stakeholder views in the development of core outcome sets: a case study in reconstructive breast surgery 2016 ·Trials ·Shelley Potter, Sara Brookes, Christopher Holcombe, Joseph Ward, Jane Blazeby	8
17	The iBRA (implant breast reconstruction evaluation) study: protocol for a prospective multi-centre cohort study to inform the feasibility, design and conduct of a pragmatic randomised clinical trial comparing new techniques of implant-based breast reconstruction 2016 ·Pilot and Feasibility Studies ·Shelley Potter, Elizabeth J. Conroy, Paula Williamson, Steven Thrush, Lisa Whisker, (unknown), Nicola Barnes, Ramsey Cutress, (unknown), Nicola Mills, Senthurun Mylvaganam, Olivier A. Branford, (unknown), Abhilash Jain, Matthew Gardiner, Jane Blazeby, Christopher Holcombe	14
18	Upper GI 01–12 2004 ·British journal of surgery ·(unknown), (unknown), Jane Blazeby, M Moorghen, (unknown), Derek Alderson	5
19	A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma 2000 ·Cancer ·Jane Blazeby, John R. Farndon, Jenny Donovan, Derek Alderson	13
20	A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma 2000 ·Cancer ·Jane Blazeby, John R. Farndon, Jenny Donovan, Derek Alderson	238

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact